Item Details

Print View

Drug Industry Antitrust Act Part 1., A.M.A. And Medical Authorities [electronic resource]: Hearings Before the United States Senate Committee on the Judiciary, Subcommittee on Antitrust and Monopoly, Eighty-Seventh Congress, First Session, on July 5, 6, 18-21, 25, 1961

United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust and Monopoly
Format
Online; EBook; Government Document
Published
Washington : U.S. G.P.O., 1961.
Language
English
Series
ProQuest U.S. Congressional Hearings Digital Collection
SuDoc Number
Y 4.J 89/2:D 84/2/pt.1
Summary
Considers S. 1552 and companion H.R. 6245, the Drug Industry Antitrust Act, to amend the Federal Food, Drug, and Cosmetic Act and Sherman Antitrust Act to establish drug company licensing procedures, to require FDA to certify the effectiveness of all new drugs, to require advertisements sent to physicians to contain FDA warnings on the drug, and to limit drug company rights to exclusive production of patented drugs.
Considers (87) S. 1552, (87) H.R. 6245.
Description
vi, 457 p. ; cm.
System requirements: PDF reader software.
Notes
  • Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection (last viewed Nov. 2009) Reuse except for individual research requires license from ProQuest, LLC.
  • Access to the Congressional Hearings Digital Collection is restricted by license to users on UVA's network. This document may also be available in print or microform at either UVa's Alderman or Law Libraries.
  • CIS No. HRG-1961-SJS-0048
  • Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection. Reuse except for individual research requires license from ProQuest, LLC.
Reproduction Notes
Electronic reproduction. [Bethesda, Md.] : ProQuest, 2004. digital, PDF file. ProQuest U.S. Congressional Hearings Digital Collection. Mode of access: World Wide Web via ProQuest website.
Copyright Not EvaluatedCopyright Not Evaluated
Technical Details
  • Staff View

    LEADER 02932nam a22003251a 4500
    001 cis2007429366
    006 m d f
    007 cr bn mmmapmmp
    008 090623s1961 dcu s f000 0 eng d
    086
    0
      
    a| Y 4.J 89/2:D 84/2/pt.1
    110
    1
      
    a| United States. b| Congress. b| Senate. b| Committee on the Judiciary. b| Subcommittee on Antitrust and Monopoly.
    245
    1
    0
    a| Drug Industry Antitrust Act. n| Part 1., p| A.M.A. and Medical Authorities h| [electronic resource] : b| hearings before the United States Senate Committee on the Judiciary, Subcommittee on Antitrust and Monopoly, Eighty-Seventh Congress, first session, on July 5, 6, 18-21, 25, 1961.
    260
      
      
    a| Washington : b| U.S. G.P.O., c| 1961.
    300
      
      
    a| vi, 457 p. ; c| cm.
    500
      
      
    a| Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection (last viewed Nov. 2009) Reuse except for individual research requires license from ProQuest, LLC.
    500
      
      
    a| Access to the Congressional Hearings Digital Collection is restricted by license to users on UVA's network. This document may also be available in print or microform at either UVa's Alderman or Law Libraries.
    500
      
      
    a| CIS No. HRG-1961-SJS-0048
    500
      
      
    a| Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection. Reuse except for individual research requires license from ProQuest, LLC.
    520
      
      
    a| Considers S. 1552 and companion H.R. 6245, the Drug Industry Antitrust Act, to amend the Federal Food, Drug, and Cosmetic Act and Sherman Antitrust Act to establish drug company licensing procedures, to require FDA to certify the effectiveness of all new drugs, to require advertisements sent to physicians to contain FDA warnings on the drug, and to limit drug company rights to exclusive production of patented drugs.
    520
      
      
    a| Considers (87) S. 1552, (87) H.R. 6245.
    533
      
      
    a| Electronic reproduction. b| [Bethesda, Md.] : c| ProQuest, d| 2004. e| digital, PDF file. n| ProQuest U.S. Congressional Hearings Digital Collection. n| Mode of access: World Wide Web via ProQuest website.
    538
      
      
    a| System requirements: PDF reader software.
    650
      
    0
    a| Antitrust law z| United States.
    650
      
    0
    a| Drugs x| Law and legislation z| United States.
    776
    0
    8
    i| Print version: a| United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust and Monopoly. t| Drug Industry Antitrust Act
    776
    0
    8
    i| Microfiche version: a| United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust and Monopoly. t| Drug Industry Antitrust Act. d| [Bethesda, Md.] : ProQuest,[2004] o| CIS Hrgs MF Gp 3--(87) S1489-0-A w| (ProQuest)cis10703409
    830
      
    0
    a| ProQuest U.S. Congressional Hearings Digital Collection.
    856
    4
    0
    u| http://proxy.its.virginia.edu/login?url=http://congressional.proquest.com/congcomp/getdoc?HEARING-ID=HRG-1961-SJS-0048 y| Electronic resource (PDF)
    998
      
      
    a| cis10703409
    040
      
      
    a| UMI c| UMI
▾See more
▴See less

Availability

Read Online